Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company RaQualia Pharma Inc.
DescriptionSerotonin (5-HT2B) antagonist
Molecular Target Serotonin (5-HT2B) receptor
Mechanism of ActionSerotonin (5-HT2B) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationIrritable bowel syndrome
Indication DetailsTreat abdominal pain, discomfort and abnormal bowel movements; Treat diarrhea-predominant irritable bowel syndrome (IBS-D)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today